Edward Franek
About
In The Last Decade
Edward Franek
152 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Endocrinology, Diabetes and Metabolism 1.5k
- Surgery 1.1k
- Orthopedics and Sports Medicine 723
- Molecular Biology 688
- Oncology 615
Countries citing papers authored by Edward Franek
This map shows the geographic impact of Edward Franek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Franek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Franek more than expected).
Fields of papers citing papers by Edward Franek
This network shows the impact of papers produced by Edward Franek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Franek. The network helps show where Edward Franek may publish in the future.
Co-authorship network of co-authors of Edward Franek
This figure shows the co-authorship network connecting the top 25 collaborators of Edward Franek. A scholar is included among the top collaborators of Edward Franek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Franek. Edward Franek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 16 | |
| 8 | Epidemiologia cukrzycy w Polsce w latach 2014–2017 | 1 |
| 9 | 17 | |
| 10 | Insulin resistance and prediabetes | 5 |
| 11 | EIGHT YEARS OF DENOSUMAB TREATMENT IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: RESULTS FROM THE FIRST FIVE YEARS OF THE FREEDOM EXTENSION | 12 |
| 12 | SGLT2 inhibitors – new oral hypoglycemic drugs | 1 |
| 13 | The role of haemodynamic and metabolic factors in the development of diabetic nephropathy | 2 |
| 14 | Glycated hemoglobin for diagnosis of diabetes in polish population of more than 45 years of age – a multicenter study | 1 |
| 15 | 47 | |
| 16 | Linear Models as Means of Analysing Possible Synergistic Effect of Periodontal Diseases and Other Risk Factors on Cardiovascular System | 0 |
| 17 | Periodontal Diseases as a Factor Modifying the Correlation Between Known Risk Factors and Atherosclerosis | 0 |
| 18 | Pierwotne, wtórne i jatrogenne zaburzenia czynności tarczycy | 0 |
| 19 | Hipokalcemia w praktyce klinicznej - przyczyny, objawy i leczenie | 0 |
| 20 | [Effect of orlistat therapy on carbohydrate, lipid, vitamin and hormone plasma levels in obese subjects]. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.